Genetic alterations in Nrf2 and its regulators are recurring events in the development and progression of NSCLC, leading to constitutive expression of transcription factor Nrf2, which neutralizes cellular ROS, which is required to maintain the redox homeostasis and protect cells against toxic xenobiotics. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.